Skip to main content
. Author manuscript; available in PMC: 2012 Feb 1.
Published in final edited form as: Pharmacol Ther. 2010 Oct 15;129(2):220–238. doi: 10.1016/j.pharmthera.2010.09.009

Table 4.

Effects of human SERT coding variants on SERT expression and regulation

hSERT variants Effect on SERT Activity (versus wild type)
Basal PKG- activation P38 MAPK-activation PKC-activation Surface expression
hSERT-WT 100% Stimulation Stimulation Inhibition 100%
Thr4Ala1 Higher Insensitive Insensitive More-sensitive Similar to WT
Gly56Ala1,3*# Higher Insensitive Insensitive More-sensitive Similar to WT
Lys201Asn2 Higher NT NT NT Similar to WT
Glu215Lys1 Similar to WT Insensitive Insensitive Similar to WT Similar to WT
Leu255Met1 Similar to WT Similar to WT Similar to WT Similar to WT Similar to WT
Ser293Phe1 Higher Similar to WT Similar to WT Similar to WT Similar to WT
Pro339Leu1 Lower Similar to WT Similar to WT Similar to WT Lower
Leu362Met1 Higher Similar to WT Similar to WT Similar to WT Similar to WT
Ile425Val11, 4 Higher Insensitive NT Similar to WT Similar/higher to WT
Ile425Leu3 Higher Less-sensitive Less-sensitive < = Less-sensitive Higher
Phe465Leu3* Higher Less-sensitive Less-sensitive < = Less-sensitive Higher
Leu550Val3 Higher Less-sensitive Less-sensitive < = Less-sensitive Higher
Lys605Asn1 Similar to WT Insensitive Insensitive More-sensitive Similar to WT
Pro621Ser1 Similar to WT Insensitive Insensitive More-sensitive Similar to WT

NT: Not tested; < = comparable or slightly reduced sensitivity in comparison with WT;

*

Less sensitive to PP2 inhibition with calyculin and fostriecin in comparison with WT;

#

exhibits elevated basal phosphorylation.